Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 54(3): 582-7, 2011 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-20934824

RESUMO

A new degradant of sultamicillin drug substance was found during the gradient reverse phase HPLC analysis of stability storage samples. The level of this degradant impurity was observed up to 1.0%. The impurity (formaldehyde adduct with 5-oxo-4-phenylimidazolidin-1-yl moiety) was identified by LC/MS and was characterized by ((1)H NMR, (13)C NMR, 2D-NMR ((1)H-(1)H COSY, NOESY, HSQC and HMBC), LC/MS/MS, MS/TOF, elemental analysis and IR. This impurity was prepared by isolation and co-injected into HPLC system to confirm the retention time.


Assuntos
Contaminação de Medicamentos , Pneumonia/tratamento farmacológico , Ampicilina/análise , Ampicilina/química , Ampicilina/farmacologia , Cromatografia Líquida de Alta Pressão , Cromatografia Líquida , Estabilidade de Medicamentos , Humanos , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Espectrofotometria Infravermelho , Sulbactam/análise , Sulbactam/química , Sulbactam/farmacologia , Espectrometria de Massas em Tandem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA